Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Sirshendu Roopom Banerjee currently holds 28,956 shares of Comera Life Sciences Holdings, Inc. (CMRA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sirshendu Roopom Banerjee has been a net buyer of CMRA stock. They have purchased $24.9K and sold $0 worth of shares.
Sirshendu Roopom Banerjee's most recent insider trade was on Jan 4, 2023, when they sold 20,270 shares at $1.23 per share.
Sirshendu Roopom Banerjee serves as Executive at Comera Life Sciences Holdings, Inc. (CMRA). They have executed 2 insider transactions totaling $24.9K over their tenure at the company.
Sirshendu Roopom Banerjee holds the position of Executive at Comera Life Sciences Holdings, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Sirshendu Roopom Banerjee has shown a buying trading pattern, with $24.9K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Sirshendu Roopom Banerjee was on Jan 4, 2023, when they purchased $24.9K worth of CMRA shares. This transaction involved 20,270 shares at $1.23 per share.
Sirshendu Roopom Banerjee currently owns 28,956 shares of Comera Life Sciences Holdings, Inc. (CMRA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Sirshendu Roopom Banerjee's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Sirshendu Roopom Banerjee has 2 Form 4 filings on record as an insider at Comera Life Sciences Holdings, Inc..
Set alerts for Sirshendu Roopom Banerjee and 40,000+ other insiders.